NCX-2057

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameNCX-2057
Drug Alias NameNCX-2057
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionApoptosis inhibitorsNeuroprotectantsantioxidant +[5] 
TargetsUpdating
Therapy Area/IndicationsInflammationAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNicox SA
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNicox SA
Active IndicationsN/A
Inactive IndicationsInflammationAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A